Patent · US Active

Inhibitors of hepatitis C virus

US9309260B2 · kind B2 · utility

1Cited by
12References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 18, 2013
Grant dateApr 12, 2016
Priority date
Expiry dateNov 18, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A class of compounds that inhibit Hepatitis C Virus (HCV) is disclosed, along with compositions containing the compound, and methods of using the composition for treating individuals infected with HCV.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.